Risperdal and Humulin n drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Risperdal (risperidone) and Humulin n (insulin susp isophane recombinant human). Common drug interactions include renal failure chronic among females and abdominal pain among males.

The phase IV clinical study analyzes what interactions people have when they take Risperdal and Humulin n. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.

What is Risperdal?

Risperdal has active ingredients of risperidone. It is often used in bipolar disorder. eHealthMe is studying from 127,729 Risperdal users. Check the latest studies of Risperdal.

What is Humulin n?

Humulin n has active ingredients of insulin susp isophane recombinant human. It is often used in diabetes. eHealthMe is studying from 9,878 Humulin n users. Check the latest studies of Humulin n.

On Jul, 11, 2026

14 people who take Risperdal and Humulin n together, and have interactions are studied.

Risperdal and Humulin n drug interactions.

What are the common drug interactions of Risperdal and Humulin N, by gender? *:

female:

Renal failure chronic (long lasting kidney dysfunction)
Urinary tract infection staphylococcal
Urinary tract obstruction
Vomiting
Basal cell carcinoma (a skin cancer, it rarely metastasizes or kills)
Concussion (short loss of normal brain function in response to a head injury)
Hypertension (high blood pressure)
Post concussion syndrome
Agoraphobia (extreme or irrational fear of crowded spaces or enclosed public places)
Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)

male:

Abdominal pain
Agitation (state of anxiety or nervous excitement)
Diarrhoea
Drug dependence
Drug ineffective
Drug tolerance increased
Drug withdrawal syndrome (interfere with normal social, occupational, or other functioning. are not due to another medical condition, drug use, or discontinuation)
Duodenitis (inflammation of the duodenum)
Dyskinesia (abnormality or impairment of voluntary movement)
Dyslipidaemia (abnormal amount of lipids)

What are the common drug interactions of Risperdal and Humulin N, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Basal cell carcinoma (a skin cancer, it rarely metastasizes or kills)
Concussion (short loss of normal brain function in response to a head injury)
Heart rate increased
Hypertension (high blood pressure)
Post concussion syndrome

40-49:

Abdominal pain
Agitation (state of anxiety or nervous excitement)
Anxiety
Azotaemia (excess of urea or other nitrogenous compounds in the blood)
Cellulitis (infection under the skin)
Cholecystitis (infection of gallbladder)
Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
Confusional state
Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
Depressed level of consciousness

50-59:

n/a

60+:

Blood cholesterol increased
Blood creatine phosphokinase increased
High density lipoprotein decreased
Lethargy (tiredness)
Nausea (feeling of having an urge to vomit)
Urinary tract infection staphylococcal
Urinary tract obstruction
Vomiting
Blood creatine phosphokinase mb increased
Blood triglycerides increased

What are the existing conditions these people have? *

Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 5 people, 35.71%
Abdominal Pain: 3 people, 21.43%
Pain: 3 people, 21.43%
Back Pain: 3 people, 21.43%
Breakthrough Pain: 2 people, 14.29%
Type 2 Diabetes: 2 people, 14.29%
Pancreatitis Chronic (chronic inflammation of pancreas): 2 people, 14.29%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 1 person, 7.14%
Joint Pain: 1 person, 7.14%
Tardive Dyskinesia (a disorder that involves involuntary movements): 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Risperdal and Humulin n?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously